Real-time enrollment status for this cervical cancer clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 11:43 PM UTC
| NCT Number | NCT06952660 |
| Recruiting Status | Recruiting |
| Condition | Cervical Cancer |
| Phase | PHASE4 |
| Target Enrollment | 100 participants |
| Active Locations | 131 sites in the US |
| Sponsor | Pfizer |
| Last Updated on CT.gov | October 13, 2026 (3 days ago) |
As of October 16, 2026: Clinical trial NCT06952660 is currently recruiting participants. This phase4 study for cervical cancer is actively seeking new participants at 131 locations across the United States. The study is sponsored by Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06952660 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 131 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06952660 was last updated 3 days ago (October 13, 2026). HelloStudys verifies this status automatically.